Active · per the CBE, 17 September 2026

GALEPHAR M/F

BE0464786485

Rechtspersoon Public limited company 1 establishment

GALEPHAR M/F is registered with the CBE as active in: Vervaardiging van geneesmiddelen. Public Limited, started on 24 December 1998, 1 establishment.

Marche, Rue du Parc Industriel 39, 6900 Marche-en-Famenne

Active for

27 year, 8 months

Financials

Financial year 2025

GALEPHAR M/F from Marche-en-Famenne, company number BE0464786485, closed financial year 2025 with a result of € 3.6 million after tax. For that financial year GALEPHAR M/F recorded revenue of € 10.8 million and equity of € 19.6 million. Compared with financial year 2024, the result moved from € 446,781 to € 3.6 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.

What it is worth Growing

€ 19.6 million

▲ 23% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 3.6 million

▲ € 3.2 million vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.8 million

▼ 75% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 17.4 million.

People and assets in 2025

Full-time equivalents

38.8

▲ 1.8 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 3.2 million

▲ 8% vs 2024

€ 82,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 133,812

▲ € 117,174 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 521

▼ 38% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 330,039

▼ 8% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 39 days on average.

Taxes and wages

€ 1.7 million

▲ 235% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Revenue € 2,744,979 € 6,169,236 € 5,424,040 € 10,790,855 ▲ 99%
Profit after taxes € 395,266 € 658,990 € 446,781 € 3,638,239 ▲ € 3.2 million
Equity € 25,850,491 € 15,509,481 € 15,956,263 € 19,594,501 ▲ 23%
Total debts € 1,243,720 € 12,160,594 € 866,095 € 1,991,556 ▲ 130%
Cash € 24,082,517 € 3,376,670 € 7,384,611 € 1,826,398 ▼ 75%
Land & buildings € 201,762 € 342,575 € 269,832 € 511,986 ▲ 90%
Retained profit € 23,619,449 € 13,278,439 € 13,725,221 € 17,363,459 ▲ 27%
Dividend € 16,000,000 € 11,000,000 € 0 € 0
Bank debt € 259 € 4,728 € 838 € 521 ▼ 38%
Balance sheet total € 27,094,211 € 27,670,075 € 16,822,358 € 21,586,057 ▲ 28%
Employees (FTE) 38 39 37 38.8 ▲ 1.8

Key figures of GALEPHAR M/F, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to GALEPHAR M/F?

What happened at GALEPHAR M/F in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • FRANCOIS BAUDIER stepped down as director. NBB
  • ARTHUR DEBOECK stepped down as director. NBB
  • New annual accounts for financial year 2025: profit of € 3.6 million (▲ € 3.2 million vs 2024). Source: NBB ↗
  • FRANCOIS BAUDIER became a director. NBB
  • ARTHUR DEBOECK became a director. NBB
  • New establishment in Marche-en-Famenne. KBO
  • Start of the company according to the CBE. KBO

In short

From € 395,266 profit in 2022 to € 3.6 million profit in 2025.

Paid € 2.6 million in corporate taxes since 2022.

Best year ever: 2025, with € 3.6 million profit.

Paid out € 27 million in dividends to the owners in total.

Management

PHILIPPE BAUDIER
GALEPHAR M/F

The shares are held by PHILIPPE BAUDIER and LABORATOIRES SMB.

See the full network in the app

Directors

According to the 2025 annual accounts

FRANCOIS BAUDIER

Managing director

since 2022 · until 2028

ARTHUR DEBOECK

Director

since 2022 · until 2028

Shareholders

PHILIPPE BAUDIER

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Marche, Rue du Parc Industriel 39

6900 Marche-en-Famenne

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0464.786.485
VAT number
BE 0464.786.485
Registered office
Marche, Rue du Parc Industriel 39, 6900 Marche-en-Famenne
Names & denominations
GALEPHAR M/F
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
24 December 1998
Peppol
Active · Active since 27 Mar 2026
Activities · NACE

Vervaardiging van geneesmiddelen

Activiteiten van medische beeldvorming en medische laboratoria

Medische laboratoria

Activiteiten van medische laboratoria

Frequently asked questions

What does GALEPHAR M/F do?
GALEPHAR M/F is registered with the CBE as active in: Vervaardiging van geneesmiddelen. Public Limited, started on 24 December 1998, 1 establishment.
What is the address of GALEPHAR M/F?
The registered office of GALEPHAR M/F is located at Marche, Rue du Parc Industriel 39, 6900 Marche-en-Famenne.
Is GALEPHAR M/F still active?
Yes. According to the CBE (17 September 2026) GALEPHAR M/F is active, legal situation “Normale toestand”, started on 24 December 1998.
Is GALEPHAR M/F registered on Peppol?
Yes, GALEPHAR M/F is registered on the Peppol network with ID 0208:0464786485.
What is the enterprise number of GALEPHAR M/F?
The enterprise number of GALEPHAR M/F is BE0464786485.
When was GALEPHAR M/F founded?
GALEPHAR M/F was founded on 24 December 1998.